lunes, 13 de agosto de 2018

Potential CF Therapy SNSP113 Able to Kill Drug-resistant Bacteria in Lab Study

Potential CF Therapy SNSP113 Able to Kill Drug-resistant Bacteria in Lab Study

Cystic Fibrosis News Today

Synspira’s SNSP113 Shows Ability to Completely Kill Drug-Resistant Bacteria in Lab, Study Reports

No hay comentarios:

Publicar un comentario